Back in September, we told you about a warning regarding Zantac and it’s generic counterpart, Ranitidine. That warning has now become a voluntary recall.
Dr. Reddy’s Laboratories, the maker of the popular drug Ranitidine, has issued a voluntary recall of its tablets and capsules.
— FDA Drug Information (@FDA_Drug_Info) October 23, 2019
The recall comes after the USFDA found N-Nitrosodimethylamine (NDMA), a known probable human carcinogen, in samples of Ranitidine.
Ranitidine is both a prescription drug and available over-the-counter under many store-brand labels. It’s taken to treat heartburn caused by acid indigestion. A full list of the products affected can be found here.
All pills with an expiration date ranging between September 2019 and March 2022 are part of the recall. So far, no reports of illness or cancer have been reported. Anyone with any questions should call 1-888-375-3784.
Copyright 2019, UnitedVoice.com